40
Participants
Start Date
May 31, 2001
Primary Completion Date
August 31, 2006
Study Completion Date
August 31, 2006
poly I-poly C12U
200-400 mg IV infusions 2x/week for 64 weeks
W. Chris Woodward, DO, Reading
Dupont Circle Physicians Group, Washington D.C.
Allied Clinical Trials, Miami
Julia Torres, MD, Fort Lauderdale
Scott Ubillos, MD, Tampa
AltaMed Health Services Corporation, Los Angeles
Orange County Center for Special Immunology, Fountain Valley
Circle Medical Center, Norwalk
St. Michael's Medical Center, Newark
Christopher Lucasti, D.O., Somers Point
Lead Sponsor
AIM ImmunoTech Inc.
INDUSTRY